Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease?

Brain, Behavior, and Immunity

Volumn 17, Issue 5, 2003, Pages 321-328

  Sephton, Sandra ^a   Spiegel, David ^b  

^a University of Louisville School of Medicine   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME; FOLLITROPIN; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; MELATONIN; PROLACTIN; PROTEIN; THYROTROPIN;

BREAST CANCER; CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER TISSUE; CIRCADIAN RHYTHM; COLON CANCER; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; GLUCONEOGENESIS; HEREDITY; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; METABOLISM; NATURAL KILLER CELL; NEUROENDOCRINE DISEASE; OSTEOSARCOMA; OVARY CANCER; PANCREAS ADENOCARCINOMA; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PSYCHOSOCIAL CARE; QUALITY OF LIFE; SHORT SURVEY; SLEEP DISORDER; SOCIAL PSYCHOLOGY; STOMACH CANCER; STRESS; TREATMENT OUTCOME; TUMOR CELL; UNEMPLOYMENT;

EID: 0041733687     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(03)00078-3     Document Type: Short Survey

References (34)

1. Andersen B.L., Kiecolt-Glaser J.K., Glaser R. A biobehavioral model of cancer stress and disease course. Am. Psychol. 49(5):1994;389-404.
2. Antoni M.H. Psychoneuroendocrinology and psychoneuroimmunology of cancer: plausible mechanisms worth pursuing? Brain Behav. Immun. 17(1 Suppl.):2003;84-91.
3. Balsalobre A., Brown S.A., Marcacci L., Tronche F., Kellendonk C., Reichardt H.M., Schutz G., Schibler U. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science. 289(5488):2000;2344-2347.
4. Chrousos G.P., Gold P.W. A healthy body in a healthy mind - and vice versa - the damaging power of "uncontrollable" stress. J. Clin. Endocrinol. Metab. 83(6):1998;1842-1845.
5. Cohen S., Rabin B.S. Psychologic stress, immunity, and cancer. J. Natl. Cancer Inst. 90(1):1998;3-4.
6. Davis S., Mirick D.K., Stevens R.G. Night shift work, light at night, and risk of breast cancer. J. Natl. Cancer Inst. 93(20):2001;1557-1562.
7. Deuschle M., Schweiger U., Weber B., Gotthardt U., Korner A., Schmider J., Standhardt H., Lammers C.H., Heuser I. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J. Clin. Endocrinol. Metab. 82(1):1997;234-238.
8. Fawzy F.I., Canada A.L., Fawzy N.W. Malignant melanoma: effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch. Gen. Psychiatry. 60(1):2003;100-103.
9. Filipski E., King V.M., Li X., Granda T.G., Mormont M.C., Liu X., Claustrat B., Hastings M.H., Levi F. Host circadian clock as a control point in tumor progression. J. Natl. Cancer Inst. 94(9):2002;690-697.
10. Fu L., Pelicano H., Liu J., Huang P., Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 111(1):2002;41-50.
11. House J.S., Landis K.R., Umberson D. Social relationships and health. Science. 241(4865):1988;540-545.
12. Kiecolt-Glaser J.K., Robles T.F., Heffner K.L., Loving T.J., Glaser R. Psycho-oncology and cancer: psychoneuroimmunology and cancer. Ann. Oncol. 13 Suppl 4:2002;165-169.
13. Leproult R., Colecchia E.F., L'Hermite-Baleriaux M., Van Cauter E. Transition from dim to bright light in the morning induces an immediate elevation of cortisol levels. J. Clin. Endocrinol. Metab. 86(1):2001;151-157.
14. Levi F. From circadian rhythms to cancer chronotherapeutics. Chronobiol. Int. 19(1):2002;1-19.
15. Levy S.M., Herberman R.B., Lippman M., D'Angelo T., Lee J. Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav. Med. 17(2):1991;67-75.
16. Madden K.S., Sanders V.M., Felten D.L. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol. 35:1995;417-448.
17. Maunsell E., Brisson J., Deschenes L. Social support and survival among women with breast cancer. Cancer. 76(4):1995;631-637.
18. McCorkle R., Strumpf N.E., Nuamah I.F., Adler D.C., Cooley M.E., Jepson C., Lusk E.J., Torosian M. A specialized home care intervention improves survival among older post-surgical cancer patients. J. Am. Geriatr. Soc. 48(12):2000;1707-1713.
19. McEwen B.S. Protective and damaging effects of stress mediators: allostasis and allostatic load. N. Engl. J. Med. 338(3):1998;171-179.
20. Mormont M.C., Bogdan A., Cormont S., Touitou Y., Levi F. Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer: relevance for clinical outcome. Anticancer Res. 22(2B):2002;1243-1249.
21. Mormont M.C., Levi F. Circadian-system alterations during cancer processes: a review. Int. J. Cancer. 70(2):1997;241-247.
22. Mormont M.C., Waterhouse J., Bleuzen P., Giacchetti S., Jami A., Bogdan A., Lellouch J., Misset J.L., Touitou Y., Levi F. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status [In Process Citation]. Clin. Cancer Res. 6(8):2000;3038-3045.
23. Ockenfels M.C., Porter L., Smyth J., Kirschbaum C., Hellhammer D.H., Stone A.A. Effect of chronic stress associated with unemployment on salivary cortisol: overall cortisol levels, diurnal rhythm, and acute stress reactivity. Psychosom. Med. 57(5):1995;460-467.
24. Reynolds P., Kaplan G.A. Social connections and risk for cancer: prospective evidence from the Alameda County Study. Behav. Med. 16(3):1990;101-110.
25. Rosmond R., Bjorntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J. Intern. Med. 247(2):2000;188-197.
26. Schernhammer E.S., Laden F., Speizer F.E., Willett W.C., Hunter D.J., Kawachi I., Colditz G.A. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J. Natl. Cancer Inst. 93(20):2001;1563-1568.
27. Sephton S.E., Sapolsky R.M., Kraemer H.C., Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 92(12):2000;994-1000.
28. Spiegel D. Effects of psychotherapy on cancer survival. Nat. Rev. Cancer. 2(5):2002;383-389.
29. Sterling P., Eyer J. Biological basis of stress-related mortality. Soc. Sci. Med. [E]. 15(1):1981;3-42.
30. Ticher A., Haus E., Ron I.G., Sackett-Lundeen L., Ashkenazi I.E. The pattern of hormonal circadian time structure (acrophase) as an assessor of breast-cancer risk. Int. J. Cancer. 65(5):1996;591-593.
31. Turner-Cobb J., Sephton S., Spiegel D. Psychosocial effects on immune function and disease progression in cancer: human studies. Ader R., Felten D., Cohen N. Psychoneuroimmunology. 2001;565-582 Academic Press, San Diego.
32. Vgontzas A.N., Chrousos G.P. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol. Metab. Clin. North Am. 31(1):2002;15-36.
33. Webster J.I., Tonelli L., Sternberg E.M. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20:2002;125-163.
34. Yehuda R. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr. Clin. North Am. 25(2):2002;341-368. vii.